Peregrine Pharmaceuticals
Country
USA
Краткое название
Peregrine Pharmaceuticals
Headquarters
14282 Franklin Avenue
Members of the board
Steven W. King,
President and CEO, Director
Paul J. Lytle,
Chief Financial Officer
Joseph S. Shan, M.P.H.,
Vice President, Clinical & Regulatory Affairs
Shelley P. M. Fussey, Ph.D,.
Vice President, Intellectual Property
Jeffrey L. Masten,
Vice President, Quality
Mark R. Ziebell, Esq.,
Vice President, General Counsel and Corporate Secretary
Jeff T. Hutchins, Ph.D.,
Vice President, Preclinical Research
Robert L. Garnick, Ph.D.,
Head of Regulatory Affairs
Kerstin B. Menander, M.D., Ph.D.,
Head of Medical Oncology
Mary J. Boyd, Ph.D.,
Head of Business Development for Asia and Europe
Categories medicine
Oncology, Infectious diseases
Stage of the project
Production
Disease
Viral hepatitis
Ticker
PPHM
Current owners
President and CEO, Director
David H. Poh,l
Director
Eric S. Swartz,
Director
Assets
256.1300
Technology
Cell Technologies, Devices, Technologies, Pharmaceuticals, Chemistry